Inside the Decision Room: How to Pressure-Test Your Value Story for Formulary Success

Inside the Decision Room: What Really Drives Formulary Placement Last week, we explored how payers are scrutinizing endpoints and comparators more closely than ever, and why validating your value story against payer expectations has become essential. But validation is...

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025 For decades, pharmaceutical market access conversations revolved around price. Could a manufacturer justify a premium? Would contracting or rebates secure preferred placement? In 2025,...

The New Normal of Iterative Market Access: Why Static Annual Research is Dead

For years, pharmaceutical manufacturers relied on static research cycles. Advisory boards, annual payer interviews, and one-time market surveys shaped pricing, access, and contracting strategies. The strategy was to gather input once, align internally, and move...

Why Early Payer Validation Is Critical to Evidence Strategy in Market Access

As the market access landscape evolves, the bar for evidence is shifting. Payers aren’t looking for more data. They’re looking for the right data. They want real-world relevance, economic clarity, and justification that feels grounded in practice. Too often, HEOR...
Next Entries »

Search by Category:

  • Commercial Strategy
  • Company News
  • Elasticity
  • Market Access
  • MAVA®
  • Patient Services
  • Policy & Regulation
  • Pricing & Contracting Strategy
  • Uncategorized

Recent Posts:

  • Designing Patient Support Programs Around Real-World Workflows
  • FRM Visibility in 2026: Why Static Reports No Longer Support Patient Access
  • The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims
  • Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance
  • Why Interoperability Is Becoming a Requirement for Modern Patient Support Programs

Search by Keyword:

#PatientSupport Contracting ROI contracting strategy Drug Launch Planning drug pricing Elasticity Elasticity tool eMAX Health eMAX Health Patient Services eMAXHealthPatientServices eMAX Health Systems EMRClaims+ Evidence Strategy Healthcare Analytics Healthcare Innovation Healthcareinnovation healthcare policy Health Economics HealthPACER HealthTech HEOR hybrid hub Hybrid Hub Models IRA Market Access MarketAccess market access strategy MAVA MAVA platform MedTech Patient Access PatientAccess PatientExperience Patient Services patient support programs payer insights Payers Payer Strategy pharmaceutical pricing Pharmaceuticals Pharmaceutical Strategy pharma commercialization Real World Evidence Reimbursement Specialty Pharmacy

eMAX Health
1686 S Federal Hwy
Suite 273
Delray Beach, FL 33483

FOLLOW US

  • About eMAX Health
  • Resources
  • MAVA Terms and Conditions
  • eMAX Privacy Policy

Cookie Consent

Cookies allow this website to function properly, improve your experience, and support how we can optimize your time on this website.

Your Privacy Choices

This website uses cookies, pixels, and other technologies to enhance your website experience. You may disable advertising and analytics tools using the settings below.

Strictly Necessary (Always Active)

These cookies are necessary for the website to function and cannot be disabled.

Analytics & Performance

These cookies help us understand how visitors use our website.

Marketing & Advertising

These cookies are used to show you relevant ads and marketing content.